Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Medicine top-ups to be allowed

November 5, 2008 Sales and Marketing NICE, par

The ban on NHS patients using top-up payments to receive privately-prescribed medicines has been lifted in a move aimed at …
News

The best two things to happen to pharma?

November 5, 2008 Sales and Marketing NHS, health checks, healthcare

Feature

Bayer’s ‘revolutionary’ anticoagulant Xarelto launched

November 4, 2008 Sales and Marketing Xarelto

Xarelto, the new anticoagulant treatment from Bayer has been launched in the UK, and is set to be among a …
News

Latest news from Datamonitor

November 3, 2008 Sales and Marketing Acomplia, Sanofi

Acomplia's EU suspension dispels illusion of blockbuster futureThe EMEA has suspended Acomplia due to the risk of serious psychiatric disorders. …
News

Call for more not-for-profit healthcare providers

October 30, 2008 Sales and Marketing NHS, hc

Healthcare provision should increasingly be modelled along social enterprise lines, according to the NHS Alliance. Not-for-profit groups of out-of-hours providers …
News

Contraceptive and Betaferon sales bolster Bayer

October 30, 2008 Sales and Marketing Bayer

Strong sales of Bayer's Yaz contraceptives and multiple sclerosis treatment Betaferon have helped third quarter pharma sales that could only …
News

Study boost for Roche’s Actemra

October 30, 2008 Research and Development, Sales and Marketing RA, Roche

New data shows Roche's Actemra (tocilizumab) increases the disease remission rate in rheumatoid arthritis (RA) sufferers. The company says the …
News

Alzheimer’s companies hope renewed by House of Lords

October 30, 2008 Sales and Marketing Alzheimer's, NICE

The companies behind Alzheimer's drug Aricept have won the right to see the economic model NICE used to assess the …
News

Strong results for Novartis drug in rare autoimmune disease

October 30, 2008 Research and Development, Sales and Marketing Novartis

Novartis' development drug ACZ885 (canakinumab) has turned in impressive results in trials for rare medical conditions. It showed sustained remission …
News

GSK to acquire Hepatitis C specialists Genelabs

October 30, 2008 Sales and Marketing GSK, Genelabs, MA

GlaxoSmithKline is to pay $57 million (£35 million) for Genelabs, California-based specialists in infectious diseases, including hepatitis C. The companies …
News

Specialising for success

October 29, 2008 Research and Development, Sales and Marketing marketing, product portfolio

From the middle of the last century, the likes of GSK, Pfizer, AstraZeneca, Bristol Myers Squibb and others have made …
Feature

Working Life: Philip Sarbutt

October 28, 2008 Research and Development, Sales and Marketing UK, Wyeth, Wyeth Pharmaceuticals, outsourcing

How did you find your way into your role?
Feature

Latest news from Datamonitor

October 28, 2008 Sales and Marketing

Targeted therapy cancer brands to achieve sales of over $42 billion by 2017Targeted therapies have improved treatment outcomes in cancer …
News

Novartis appoints Reinhardt as chief operating officer

October 24, 2008 Sales and Marketing Novartis

Novartis has shaken up its senior management structure with the creation of a new post – chief operating officer. From …
News

Merck to streamline management structure

October 24, 2008 Sales and Marketing Merck

Merck has announced a new round of job cuts and restructuring in a bid to update its business model and …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026